Lee, Danner & Bass’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-23,120
| Closed | -$2.3M | – | 184 |
|
|
2019
Q3 | $2.3M | Buy |
23,120
+200
| +0.9% | +$19K | 0.25% | 83 |
|
|
2019
Q2 | $2.12M | Sell |
22,920
-1,803
| -7% | -$171K | 0.22% | 87 |
|
|
2019
Q1 | $2.33M | Buy |
24,723
+5,843
| +31% | +$511K | 0.26% | 76 |
|
|
2018
Q4 | $1.21M | Buy |
18,880
+490
| +3% | +$36.2K | 0.14% | 104 |
|
|
2018
Q3 | $1.65M | Sell |
18,390
-1,738
| -9% | -$154K | 0.16% | 97 |
|
|
2018
Q2 | $1.6M | Buy |
20,128
+4,780
| +31% | +$397K | 0.17% | 97 |
|
|
2018
Q1 | $1.37M | Buy |
15,348
+4,597
| +43% | +$441K | 0.14% | 105 |
|
|
2017
Q4 | $1.12M | Buy |
10,751
+5,518
| +105% | +$623K | 0.11% | 109 |
|
|
2017
Q3 | $763K | Sell |
5,233
-70
| -1% | -$9.54K | 0.08% | 117 |
|
|
2017
Q2 | $689K | Buy |
5,303
+84
| +2% | +$10.3K | 0.08% | 119 |
|
|
2017
Q1 | $649K | Sell |
5,219
-240
| -4% | -$28.7K | 0.07% | 118 |
|
|
2016
Q4 | $632K | Sell |
5,459
-25
| -0.5% | -$2.78K | 0.07% | 117 |
|
|
2016
Q3 | $573K | Sell |
5,484
-950
| -15% | -$103K | 0.07% | 116 |
|
|
2016
Q2 | $635K | Sell |
6,434
-492
| -7% | -$50.9K | 0.08% | 115 |
|
|
2016
Q1 | $745K | Sell |
6,926
-1,724
| -20% | -$178K | 0.09% | 109 |
|
|
2015
Q4 | $1.04M | Buy |
8,650
+6,000
| +226% | +$694K | 0.14% | 98 |
|
|
2015
Q3 | $287K | Buy |
2,650
+20
| +0.8% | +$2.48K | 0.04% | 144 |
|
|
2015
Q2 | $304K | Sell |
2,630
-200
| -7% | -$22.9K | 0.04% | 145 |
|
|
2015
Q1 | $326K | Buy |
2,830
+22
| +0.8% | +$2.63K | 0.04% | 140 |
|
|
2014
Q4 | $314K | Buy |
2,808
+70
| +3% | +$7.38K | 0.04% | 139 |
|
|
2014
Q3 | $260K | Sell |
2,738
-8
| -0.3% | -$722 | 0.03% | 144 |
|
|
2014
Q2 | $236K | Sell |
2,746
-384
| -12% | -$29.2K | 0.03% | 147 |
|
|
2014
Q1 | $218K | Buy |
+3,130
| New | +$248K | 0.03% | 148 |
|
Other funds holding CELG
FP
HCM
PCMC
WCG
Lee, Danner & Bass's CELG Position: Q4 2019 in Review
Lee, Danner & Bass sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 23,120 shares — an estimated $2.3M sold.
Lee, Danner & Bass first reported a position in CELG in Q1 2014 and held it in 23 quarters. The position peaked at $2.33M in Q1 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- Lee, Danner & Bass reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- Lee, Danner & Bass sold 23,120 Celgene Corp shares in Q4 2019, an estimated $2.3M.
- Lee, Danner & Bass first reported a position in Celgene Corp in Q1 2014 and held it in 23 quarters.
- Lee, Danner & Bass's Celgene Corp position peaked at $2.33M in Q1 2019.
- 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on Lee, Danner & Bass's 13F filing for Q4 2019, filed 13 Feb 2020.